Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Only stupid people say others are stupid......
Look up what Karuna Therapeutics got bought out for, makes $40 a share look like chump change!!!
Going 40$ soon 🔜 💥
I agree, the only thing that is going to move the share price now is bigger money like companies and institutions. I think the role of retail investors is limited at this point. All the catalysts are in place for deep pockets to swoop in!
Why do you make these stupid predictions all the time? You're looking foolish.
I think we are trading in this range for a while
Got it. Will look at begi. My other big one is AGSS. Quiet before the storm
That POS followed me over here from BEGI, my other big position, when MNMD goes ballistic and or recieves a buyout, I committed my MNMD gains to buying up BEGI.
That was yday….
Awesome close today! This will start to hold above $11 very soon!!!
Somebody bought big today! Big block buyer out there, I like their style!
Agreed. Friday was a disappointment
Close at $11+ today.......
I didn't catch that one, it could've been a fat finger mistake. If it wasn't, I'm not sure it would surge the price high enough to incur a halt...I could be wrong though lol...
That 200 k buy in 1 go
This should be an exciting week, we're undervalued at this point by a factor of 3!!! I think this week should build up the share price quite considerably!!!
I had a feeling we would drop below ten. Great day even though we were up about 10% most of the day. We pushed higher which is great
I thought we we're gonna break $11, let see what after hours does, I'm not concerned, we're still undervalued in my opinion by a multiple of 3!
Tho k we will close above 10?
Yes Sir! Been here since Toronto and hoping to end up in Croatia!!!
With going into Phase 3 and having FDA Breakthrough designation, this stock should be wayyyyyyy more appropriately valued at $27+ per share!!!!!!! Bigger money is coming!!!
$10 is a great area, looks cheap to retail investors and is expensive enough for institutional investors.
Will win over time.
MNMD seems to like hovering in the approxomate $10 range for the time being. I think it is still vastly vastly undervalued!
Agreed. This is unquestionably a buy & hold stock.
Big money and institutions are coming back in, nothing better for both the stock price and shareholder value!!! With the FDA Breakthrough designation and entrance into Phase 3, MindMed should have a bare minimum market cap of $1.7 billion dollars. MNMD is wayyyyyyy undervalued at this stage!!!!!!!
There was a 13G filing late Friday.
Looks like a fund bought 6,666,667 shares and is now a voting member at 9.5% ownership of MNMD.
I believe this is a very positive signal.
When this think blows up, you will be finished
Im probably right on this one.
I hope you are right!
It won't go that low. Offer was at 6.00. You'll never see those numbers. Hold. Check back in 12 months.
Glad I added yday. Will buy down to $4-5 if need to
End of 2025 or early 2026... P3 is when they will get sponsorship from big pharma... This one is a no brainer!
<< When do you think phase 3 will be done? 2025? 2026? >>
I think I read somewhere that it will take about 18 months, but I could be wrong.
When do you think phase 3 will be done? 2025? 2026? Thanks
Bought in at $8.20 this morning. Sounds great eh?
Now, for the rest of the story. Took a huge hit on the way down previously
But staying with it until the end this time
GLTA
We All Know it’s Gonna Happen
Congress has numerous banking bills for cannabis they’re just dragging their asses as they do with everything. My guess is that the election cycle will provide some mono as politicians up for election will tease federal legalization.
As for LSD, if the FDA is allowing fast-track status the DEA will be forced to get in line. Not only is it bad optics to have the DEA saying LSD is Schedule 1 while the FDA says it’s effective medicine but there are potential lawsuits from companies like MNMD for not allowing the medication to market
You Should - But Be Prepared to Sell Shares
I got super lucky, sold 30 Mar 15 10cc before the run up for $450 in premium and was able to close them yesterday for a meager $140 gain. I would’ve been happy selling the shares at 10per but I’d rather hold on to them.
I did manage some intraday scalps with cover calls over the past few days and I have a nice chunk of Jun 21 7c that I’ve already cleared some with 1000% gains so riding free money.
Oh, and I have some Mar 15 10p that I sold the other day on the drop. I’m debating whether to close those or let em ride until Friday. Either way I’ll either be assigned the shares or use the profits to buy more shares.
Like I said a few weeks ago, it’s nice to see the options premiums heating up. Great way to hedge and generate cash
Followers
|
194
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
9388
|
Created
|
02/18/20
|
Type
|
Free
|
Moderators MomsSpaghetti Savannah-Marc |
Location: New York, NY / Toronto, Ontario
Flagship Products: LSD, 18-MC and other psychedelics
Treatment Focus: Addiction, ADHD, Anxiety, Depression, Headaches
Ticker: $MNMD (NASDAQ), $MMED (NEO), $MMQ (DAX),
Financial Reports: Link
SEC Filings: Link
SEDAR Filings: Link
IN THE MEDIA
”Could the Embrace of Psychedelics Lead to a Mental-Health Revolution?”, Vogue
”Psychedelics-Drug Startup Raises $24 Million Ahead of IPO”, Wall Street Journal
”Silicon Valley’s psychedelic wonder drug is almost here”, Fast Company
”Psychedelic drug company MindMed applies for nasdaq up-listing”, Forbes
”Psychedelic drugs may transform mental health care. And big business is ready to profit from the revolution”, Fortune
”A startup that wants to use psychedelics to treat addiction just raised $6.2 million from the host of Shark Tank and the architect behind the world’s biggest cannabis grower”, Business Insider
”New York is getting its first psychedelic-medicine center, with the help of a startup called MindMed, which develops hallucinogens to treat mental illness and addiction, and is funding an institute at N.Y.U. Langone Medical Center”, The New Yorker
”MindMed surges, putting it at the forefront of psychedelic euphoria”, Bloomberg
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |